421 related articles for article (PubMed ID: 33910229)
1. PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism.
Ren AA; Snellings DA; Su YS; Hong CC; Castro M; Tang AT; Detter MR; Hobson N; Girard R; Romanos S; Lightle R; Moore T; Shenkar R; Benavides C; Beaman MM; Müller-Fielitz H; Chen M; Mericko P; Yang J; Sung DC; Lawton MT; Ruppert JM; Schwaninger M; Körbelin J; Potente M; Awad IA; Marchuk DA; Kahn ML
Nature; 2021 Jun; 594(7862):271-276. PubMed ID: 33910229
[TBL] [Abstract][Full Text] [Related]
2. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.
Zhou Z; Tang AT; Wong WY; Bamezai S; Goddard LM; Shenkar R; Zhou S; Yang J; Wright AC; Foley M; Arthur JS; Whitehead KJ; Awad IA; Li DY; Zheng X; Kahn ML
Nature; 2016 Apr; 532(7597):122-6. PubMed ID: 27027284
[TBL] [Abstract][Full Text] [Related]
3. mTORC1 Inhibitor Rapamycin Inhibits Growth of Cerebral Cavernous Malformation in Adult Mice.
Li L; Ren AA; Gao S; Su YS; Yang J; Bockman J; Mericko-Ishizuka P; Griffin J; Shenkar R; Alcazar R; Moore T; Lightle R; DeBiasse D; Awad IA; Marchuk DA; Kahn ML; Burkhardt JK
Stroke; 2023 Nov; 54(11):2906-2917. PubMed ID: 37746705
[TBL] [Abstract][Full Text] [Related]
4. Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation.
Weng J; Yang Y; Song D; Huo R; Li H; Chen Y; Nam Y; Zhou Q; Jiao Y; Fu W; Yan Z; Wang J; Xu H; Di L; Li J; Wang S; Zhao J; Wang J; Cao Y
Am J Hum Genet; 2021 May; 108(5):942-950. PubMed ID: 33891857
[TBL] [Abstract][Full Text] [Related]
5. Endothelial hyperactivation of mutant MAP3K3 induces cerebral cavernous malformation enhanced by PIK3CA GOF mutation.
Huo R; Yang Y; Sun Y; Zhou Q; Zhao S; Mo Z; Xu H; Wang J; Weng J; Jiao Y; Zhang J; He Q; Wang S; Zhao J; Wang J; Cao Y
Angiogenesis; 2023 May; 26(2):295-312. PubMed ID: 36719480
[TBL] [Abstract][Full Text] [Related]
6. KLF4 is a key determinant in the development and progression of cerebral cavernous malformations.
Cuttano R; Rudini N; Bravi L; Corada M; Giampietro C; Papa E; Morini MF; Maddaluno L; Baeyens N; Adams RH; Jain MK; Owens GK; Schwartz M; Lampugnani MG; Dejana E
EMBO Mol Med; 2016 Jan; 8(1):6-24. PubMed ID: 26612856
[TBL] [Abstract][Full Text] [Related]
7. CDC42 Deletion Elicits Cerebral Vascular Malformations via Increased MEKK3-Dependent KLF4 Expression.
Castro M; Laviña B; Ando K; Álvarez-Aznar A; Abu Taha A; Brakebusch C; Dejana E; Betsholtz C; Gaengel K
Circ Res; 2019 Apr; 124(8):1240-1252. PubMed ID: 30732528
[TBL] [Abstract][Full Text] [Related]
8. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
[TBL] [Abstract][Full Text] [Related]
9. Cerebral Cavernous Malformations Develop Through Clonal Expansion of Mutant Endothelial Cells.
Detter MR; Snellings DA; Marchuk DA
Circ Res; 2018 Oct; 123(10):1143-1151. PubMed ID: 30359189
[TBL] [Abstract][Full Text] [Related]
10. Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations.
Choi JP; Wang R; Yang X; Wang X; Wang L; Ting KK; Foley M; Cogger V; Yang Z; Liu F; Han Z; Liu R; Baell J; Zheng X
Sci Adv; 2018 Nov; 4(11):eaau0731. PubMed ID: 30417093
[TBL] [Abstract][Full Text] [Related]
11. Low fluid shear stress conditions contribute to activation of cerebral cavernous malformation signalling pathways.
Li J; Zhao Y; Coleman P; Chen J; Ting KK; Choi JP; Zheng X; Vadas MA; Gamble JR
Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165519. PubMed ID: 31369819
[TBL] [Abstract][Full Text] [Related]
12. Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formation.
Lopez-Ramirez MA; Lai CC; Soliman SI; Hale P; Pham A; Estrada EJ; McCurdy S; Girard R; Verma R; Moore T; Lightle R; Hobson N; Shenkar R; Poulsen O; Haddad GG; Daneman R; Gongol B; Sun H; Lagarrigue F; Awad IA; Ginsberg MH
J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34043589
[TBL] [Abstract][Full Text] [Related]
13. Endothelial Cell-Pericyte Interactions in the Pathogenesis of Cerebral Cavernous Malformations (CCMs).
Min W; Zhou JH
Cold Spring Harb Perspect Med; 2023 Mar; 13(3):. PubMed ID: 35667709
[TBL] [Abstract][Full Text] [Related]
14. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis.
Akers AL; Johnson E; Steinberg GK; Zabramski JM; Marchuk DA
Hum Mol Genet; 2009 Mar; 18(5):919-30. PubMed ID: 19088123
[TBL] [Abstract][Full Text] [Related]
15. Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis.
McDonald DA; Shi C; Shenkar R; Gallione CJ; Akers AL; Li S; De Castro N; Berg MJ; Corcoran DL; Awad IA; Marchuk DA
Hum Mol Genet; 2014 Aug; 23(16):4357-70. PubMed ID: 24698976
[TBL] [Abstract][Full Text] [Related]
16. Somatic variants of MAP3K3 are sufficient to cause cerebral and spinal cord cavernous malformations.
Ren J; Huang Y; Ren Y; Tu T; Qiu B; Ai D; Bi Z; Bai X; Li F; Li JL; Chen XJ; Feng Z; Guo Z; Lei J; Tian A; Cui Z; Lindner V; Adams RH; Wang Y; Zhao F; Körbelin J; Sun W; Wang Y; Zhang H; Hong T; Ge WP
Brain; 2023 Sep; 146(9):3634-3647. PubMed ID: 36995941
[TBL] [Abstract][Full Text] [Related]
17. Somatic
Peyre M; Miyagishima D; Bielle F; Chapon F; Sierant M; Venot Q; Lerond J; Marijon P; Abi-Jaoude S; Le Van T; Labreche K; Houlston R; Faisant M; Clémenceau S; Boch AL; Nouet A; Carpentier A; Boetto J; Louvi A; Kalamarides M
N Engl J Med; 2021 Sep; 385(11):996-1004. PubMed ID: 34496175
[TBL] [Abstract][Full Text] [Related]
18. Single-nucleus DNA sequencing reveals hidden somatic loss-of-heterozygosity in Cerebral Cavernous Malformations.
Ressler AK; Snellings DA; Girard R; Gallione CJ; Lightle R; Allen AS; Awad IA; Marchuk DA
Nat Commun; 2023 Nov; 14(1):7009. PubMed ID: 37919320
[TBL] [Abstract][Full Text] [Related]
19. The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression.
Zhou Z; Rawnsley DR; Goddard LM; Pan W; Cao XJ; Jakus Z; Zheng H; Yang J; Arthur JS; Whitehead KJ; Li D; Zhou B; Garcia BA; Zheng X; Kahn ML
Dev Cell; 2015 Jan; 32(2):168-80. PubMed ID: 25625206
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cell clonal expansion in the development of cerebral cavernous malformations.
Malinverno M; Maderna C; Abu Taha A; Corada M; Orsenigo F; Valentino M; Pisati F; Fusco C; Graziano P; Giannotta M; Yu QC; Zeng YA; Lampugnani MG; Magnusson PU; Dejana E
Nat Commun; 2019 Jun; 10(1):2761. PubMed ID: 31235698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
